|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.5 USD | -0.58% |
|
-2.80% | +16.97% |
| May. 02 | Merck: encouraging results in gastric cancer | CF |
| May. 01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
Merck & Co., Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 15,775 million compared to USD 14,487 million a year ago. Net income was USD 4,762 million compared to USD 2,821 million a year ago.
Diluted earnings per share from continuing operations was USD 1.87 compared to USD 1.11 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +16.97% | 323B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B | |
| +1.72% | 123B |
MERCK & CO., INC. 
